Latest News about GSK
Recent news which mentions GSK
Spero Therapeutics (SPRO) Soars 137% on Exclusive License Agreement
September 22, 2022
From InvestorPlace
From Benzinga
From InvestorPlace
From Benzinga
Jim Cramer Says This Stock Is A 'Great Spec And I Usually Don't Say That,' And Analysts Approve
September 21, 2022
From Benzinga
3 Biotech Stocks to Buy Now for Extraordinary Gains
September 20, 2022
From InvestorPlace
2 Dividend Stocks to Double Up On Right Now
September 20, 2022
From Motley Fool
Haleon Clocks Double Digit Growth In Interim Revenue, Profits; Sticks To Annual Guidance
September 20, 2022
From Benzinga
Haleon Shares Pop After Rejecting Zantac Indemnification Requests From GSK, Pfizer
September 20, 2022
From Benzinga
Theravance Outlines $250M Capital Return Program; To Repurchase GSK's Entire Holdings
September 19, 2022
From Benzinga
From Benzinga
Pfizer's Pentavalent Meningococcal Vaccine Candidate Shows Efficacy In Adolescents
September 15, 2022
From Benzinga
AnaptysBio Sells Royalty Interest In Cancer Drug For $45M
September 12, 2022
From Benzinga
SpringWorks Shares Pop After Expanded Multiple Myeloma Pact With GSK
September 07, 2022
From Benzinga
Sanofi-GSK COVID-19 Vaccine May See European Approval Soon: Report
September 06, 2022
From Benzinga
2 Top Trends to Invest $2,000 in Ahead of the Crowd
September 05, 2022
From Motley Fool
White House May Ask For $25B Emergency Funding For COVID-19, Monkeypox
September 02, 2022
From Benzinga
Novartis Appoints Merck Executive As Research Head
September 01, 2022
From Benzinga
With Approval For Dengue Vaccine, Takeda May Find It Challenging To Compete Bigger Rivals: Report
August 30, 2022
From Benzinga
IDEAYA Achieves First Milestone In GSK Pact For Pol Theta Helicase Inhibitor Candidate
August 29, 2022
From Benzinga
3 Dependable Stocks With Dividend Yields Above 5%
August 24, 2022
From Motley Fool
The Rise and Fall of Novavax
August 21, 2022
From Motley Fool
Fighting Omicron: This Covid Vaccine Candidate Is Going After The Dangerous Mutation
August 18, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
August 18, 2022
From Benzinga
AstraZeneca Slaps Lawsuit Against Former Employee As He Moves To Close Rival: Report
August 17, 2022
From Benzinga
One Suit Down Out Of 3,000 Zantac Related Lawsuits, Says GSK
August 17, 2022
Tickers
GSK
From Benzinga
From MarketWatch
Why IDEAYA Biosciences Shares Plunging Today
August 15, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.